Počet záznamov: 1
LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis
SYS 0169317 LBL 00000naa^^22^^^^^^^^450 005 20210128105409.3 100 $a 20201124d2020 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis $f C. Xu ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0168806 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 67, no. 4 (2020), s. 782-793 $1 210 $a Bratislava $c AEPress $d 2020 $1 215 $a s. 715-945 606 1-
$3 sllk_un_auth*d010051 $a nádory vaječníkov $2 mesh 606 1-
$3 sllk_un_auth*d062085 $a RNA dlhá nekódujúca $2 mesh 606 2-
$3 sllk_un_auth*d051900 $a Smad3 proteín $2 mesh 606 2-
$3 sllk_un_auth*d035683 $a mikroRNA $2 mesh 606 2-
$3 sllk_un_auth*d014407 $a bunky nádorové kultivované $2 mesh 610 2-
$a lncRNA CDKN2B-AS1 (cyclin-dependent kinase inhibitor 2B antisense RNA1) 610 2-
$a miRNA-143-3p 610 2-
$a štúdia experimentálna 701 -1
$3 sllk_un_auth*0030652 $a Xu $b C. $4 070 801 -0
$a SK $b BA006 $c 20201124 $g AACR2
Počet záznamov: 1